PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER AND OTHER INDICATIONS INDICATIONS

NIH RePORTER · NIH · N01 · $375,416 · view on reporter.nih.gov ↗

Abstract

The test agent is being considered for development of an anticancer therapeutic.

Key facts

NIH application ID
11124482
Project number
75N91022C00010-P00009-9999-2
Recipient
IIT RESEARCH INSTITUTE
Principal Investigator
DAVID L. MCCORMICK
Activity code
N01
Funding institute
NIH
Fiscal year
2024
Award amount
$375,416
Award type
Project period
2022-04-01 → 2025-03-31